Updated Jan. 9, 2024 3:07 am ETGSK is buying biopharmaceutical company Aiolos Bio for up to $1.4 billion ...
Updated Jan. 9, 2024 3:07 am ETGSK is buying biopharmaceutical company Aiolos Bio for up to $1.4 billion in a deal that expands its respiratory pipeline and follows a string of pharmaceutical majors b ...